Published in Neurology on October 22, 1999
Current status of the congenital myasthenic syndromes. Neuromuscul Disord (2011) 1.60
Origins and divergence of the Roma (gypsies). Am J Hum Genet (2001) 1.53
Current approach to seronegative myasthenia. J Neurol (2010) 1.46
Genetic studies of the Roma (Gypsies): a review. BMC Med Genet (2001) 1.28
Mutation history of the roma/gypsies. Am J Hum Genet (2004) 1.24
A novel locus for autosomal recessive peripheral neuropathy in the EGR2 region on 10q23. Am J Hum Genet (2000) 0.95
A retrospective clinical study of the treatment of slow-channel congenital myasthenic syndrome. J Neurol (2011) 0.91
The phylogeography of Y-chromosome haplogroup h1a1a-m82 reveals the likely Indian origin of the European Romani populations. PLoS One (2012) 0.86
AChR deficiency due to epsilon-subunit mutations: two common mutations in the Netherlands. J Neurol (2009) 0.79
Congenital myasthenic syndrome in Israel: Genetic and clinical characterization. Neuromuscul Disord (2016) 0.77
A Missense Mutation in Epsilon-subunit of Acetylcholine Receptor Causing Autosomal Dominant Slow-channel Congenital Myasthenic Syndrome in a Chinese Family. Chin Med J (Engl) (2016) 0.75
Calcium transients in isolated amphibian skeletal muscle fibres: detection with aequorin. J Physiol (1978) 6.55
The dynamic chloride component of membrane current in Purkinje fibers. Pflugers Arch Gesamte Physiol Menschen Tiere (1967) 2.90
YidC, the Escherichia coli homologue of mitochondrial Oxa1p, is a component of the Sec translocase. EMBO J (2000) 2.70
Evidence for high-energy extraterrestrial neutrinos at the IceCube detector. Science (2013) 2.56
Xeroderma pigmentosum complementation group C cells remove pyrimidine dimers selectively from the transcribed strand of active genes. Mol Cell Biol (1991) 2.53
Serum matrix metalloproteinase-9 (MMP-9) as a biomarker for monitoring disease progression in Duchenne muscular dystrophy (DMD). Neuromuscul Disord (2011) 2.47
The Sec61p complex mediates the integration of a membrane protein by allowing lipid partitioning of the transmembrane domain. Cell (2000) 2.46
Interpretation of light diffraction by cross-striated muscle as Bragg reflexion of light by the lattice of contractile proteins. J Physiol (1979) 2.40
The route of administration is a major determinant of the transduction efficiency of rat tissues by adenoviral recombinants. Gene Ther (1995) 2.39
Membrane changes in cells from myotonia patients. Physiol Rev (1985) 2.38
Single bilayer vesicles prepared without sonication. Physico-chemical properties. Biochim Biophys Acta (1976) 2.32
The protein-conducting channel in the membrane of the endoplasmic reticulum is open laterally toward the lipid bilayer. Cell (1995) 2.27
Gas-liquid chromatographic determination of human fecal bile acids. J Lipid Res (1968) 2.21
A 42K outer-membrane protein is a component of the yeast mitochondrial protein import site. Nature (1989) 2.18
CSF filtration is an effective treatment of Guillain-Barré syndrome: a randomized clinical trial. Neurology (2001) 2.16
Excitatory membrane current in heart muscle (Purkinje fibers). Pflugers Arch Gesamte Physiol Menschen Tiere (1966) 2.15
The potassium component of membrane current in Purkinje fibers. Pflugers Arch Gesamte Physiol Menschen Tiere (1967) 2.14
Creatine therapy in myophosphorylase deficiency (McArdle disease): a placebo-controlled crossover trial. Arch Neurol (2000) 2.12
Striated muscle fibers: inactivation of contraction induced by shortening. Science (1970) 2.08
Fatal outcome in two girls with hodgkin disease complicating ataxia-telangiectasia (Louis-Bar syndrome) despite favorable response to modified-dose chemotherapy. Med Pediatr Oncol (2000) 2.02
First observation of PeV-energy neutrinos with IceCube. Phys Rev Lett (2013) 2.00
Voltage and time dependence of excitatory sodium current in cooled sheep Purkinje fibres. Pflugers Arch (1970) 1.97
Complete DNA sequence of yeast chromosome II. EMBO J (1994) 1.97
Identification of a putative membrane receptor for the bioactive phospholipid, lysophosphatidic acid. EMBO J (1992) 1.97
Hydrophobic binding of the ectodomain of influenza hemagglutinin to membranes occurs through the "fusion peptide". J Biol Chem (1989) 1.96
The effect of tetrodotoxin on the membrane current in cardiac muscle (Purkinje fibers). Pflugers Arch Gesamte Physiol Menschen Tiere (1967) 1.95
Adynamia episodica hereditaria with myotonia: a non-inactivating sodium current and the effect of extracellular pH. Muscle Nerve (1987) 1.94
Enzyme replacement therapy with alglucosidase alfa in 44 patients with late-onset glycogen storage disease type 2: 12-month results of an observational clinical trial. J Neurol (2009) 1.90
Do laser diffraction studies on striated muscle indicate stepwise sarcomere shortening? Nature (1979) 1.87
Photolabeling identifies a putative fusion domain in the envelope glycoprotein of rabies and vesicular stomatitis viruses. J Biol Chem (1995) 1.80
An aspartic acid residue important for voltage-dependent gating of human muscle chloride channels. Neuron (1995) 1.79
Screening for Duchenne muscular dystrophy: an improved screening test for creatine kinase and its application in an infant screening program. Muscle Nerve (1986) 1.79
DIT101 (CSD2, CAL1), a cell cycle-regulated yeast gene required for synthesis of chitin in cell walls and chitosan in spore walls. Yeast (1992) 1.75
Molecular mechanism of membrane protein integration into the endoplasmic reticulum. Cell (1997) 1.70
Complete remission of a diffuse pontine glioma. Neuropediatrics (1998) 1.69
Discrimination between SRP- and SecA/SecB-dependent substrates involves selective recognition of nascent chains by SRP and trigger factor. EMBO J (2000) 1.68
An agrin minigene rescues dystrophic symptoms in a mouse model for congenital muscular dystrophy. Nature (2001) 1.65
Cyclosporine A treatment for Ullrich congenital muscular dystrophy: a cellular study of mitochondrial dysfunction and its rescue. Brain (2008) 1.65
Membrane interaction of influenza virus M1 protein. Virology (2000) 1.63
Mildly affected patients with spinal muscular atrophy are partially protected by an increased SMN2 copy number. Hum Genet (2006) 1.62
Calcium transients in amphibian muscle. Fed Proc (1975) 1.61
Molecular basis of AMP deaminase deficiency in skeletal muscle. Proc Natl Acad Sci U S A (1992) 1.61
Gastrointestinal dysfunction in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord (1999) 1.60
Hosts as ecological traps for the vector of Lyme disease. Proc Biol Sci (2009) 1.59
Evaluation of a PCR assay for identification and differentiation of Campylobacter fetus subspecies. Aust Vet J (1997) 1.58
Sec-dependent membrane protein insertion: sequential interaction of nascent FtsQ with SecY and YidC. EMBO Rep (2001) 1.57
In vitro contracture test for diagnosis of malignant hyperthermia following the protocol of the European MH Group: results of testing patients surviving fulminant MH and unrelated low-risk subjects. The European Malignant Hyperthermia Group. Acta Anaesthesiol Scand (1997) 1.57
Induction of an Extracellular Ribonuclease in Cultured Tomato Cells upon Phosphate Starvation. Plant Physiol (1990) 1.56
Mechanism of voltage-dependent gating in skeletal muscle chloride channels. Biophys J (1996) 1.56
Cathepsin D targeted by acid sphingomyelinase-derived ceramide. EMBO J (1999) 1.56
Lipid interactions of the hemagglutinin HA2 NH2-terminal segment during influenza virus-induced membrane fusion. J Biol Chem (1992) 1.53
Inflammatory cytokines in subarachnoid haemorrhage: association with abnormal blood flow velocities in basal cerebral arteries. J Neurol Neurosurg Psychiatry (2001) 1.53
H+-induced membrane insertion of influenza virus hemagglutinin involves the HA2 amino-terminal fusion peptide but not the coiled coil region. J Biol Chem (1996) 1.52
An endogenous pentapeptide acting as a sodium channel blocker in inflammatory autoimmune disorders of the central nervous system. Nat Med (2000) 1.50
Striated muscle fibers: facilitation of contraction at short lengths by caffeine. Science (1971) 1.50
Low-pH induced conformational changes in viral fusion proteins: implications for the fusion mechanism. J Gen Virol (1995) 1.50
The mode of association of the enzyme complex sucrase.isomaltase with the intestinal brush border membrane. J Biol Chem (1979) 1.50
Selective labeling of the hydrophobic core of membranes with 3-(trifluoromethyl)-3-(m-[125I]iodophenyl)diazirine, a carbene-generating reagent. Biochemistry (1981) 1.49
Identification of a set of yeast genes coding for a novel family of putative ATPases with high similarity to constituents of the 26S protease complex. Yeast (1994) 1.47
Increased calcium entry into dystrophin-deficient muscle fibres of MDX and ADR-MDX mice is reduced by ion channel blockers. J Physiol (1999) 1.47
[New type of recessive X-linked muscular dystrophy: scapulo-humeral-distal muscular dystrophy with early contractures and cardiac arrhythmias]. Humangenetik (1972) 1.45
Location and type of mutation in the LIS1 gene do not predict phenotypic severity. Neurology (2007) 1.45
Differential regulation of three functional ammonium transporter genes by nitrogen in root hairs and by light in leaves of tomato. Plant J (2000) 1.44
Evidence for H(+)-induced insertion of influenza hemagglutinin HA2 N-terminal segment into viral membrane. J Biol Chem (1994) 1.44
Oncological management of pediatric cancer patients belonging to Jehovah's Witnesses: a two-institutional experience report. Onkologie (2004) 1.44
Hypokalemic periodic paralysis: in vitro investigation of muscle fiber membrane parameters. Muscle Nerve (1984) 1.44
Inflammatory demyelinating neuropathy in patients with end-stage renal disease receiving continuous ambulatory peritoneal dialysis (CAPD) Perit Dial Int (1998) 1.43
Phenotypic variability in rippling muscle disease. Neurology (1999) 1.43
YidC, an assembly site for polytopic Escherichia coli membrane proteins located in immediate proximity to the SecYE translocon and lipids. EMBO Rep (2001) 1.41
Direct and GTP-dependent interaction of ADP ribosylation factor 1 with coatomer subunit beta. Proc Natl Acad Sci U S A (1997) 1.41
Two cases of adynamia episodica hereditaria: in vitro investigation of muscle cell membrane and contraction parameters. Muscle Nerve (1983) 1.39
High frequency of co-segregating CLCN1 mutations among myotonic dystrophy type 2 patients from Finland and Germany. J Neurol (2008) 1.37
The hydrophobic anchor of small-intestinal sucrase--isomaltase: N-terminal sequence of isomaltase subunit. FEBS Lett (1978) 1.37
Nascent Lep inserts into the Escherichia coli inner membrane in the vicinity of YidC, SecY and SecA. FEBS Lett (2000) 1.36
Phosphate-Regulated Induction of Intracellular Ribonucleases in Cultured Tomato (Lycopersicon esculentum) Cells. Plant Physiol (1992) 1.35
Electrostatic and hydrophobic interactions of synapsin I and synapsin I fragments with phospholipid bilayers. J Cell Biol (1989) 1.35
Ceramide-binding and activation defines protein kinase c-Raf as a ceramide-activated protein kinase. Proc Natl Acad Sci U S A (1996) 1.34
Sequence of a cDNA clone encompassing the complete mature human prostate specific antigen (PSA) and an unspliced leader sequence. Nucleic Acids Res (1988) 1.33
A diffractometer using a lateral effect photodiode for the rapid determination of sarcomere length changes in cross-striated muscle. Pflugers Arch (1978) 1.33
Coenzyme Q10 deficiency and isolated myopathy. Neurology (2006) 1.32
Molecular diagnosis of culture negative infective endocarditis: clinical validation in a group of surgically treated patients. Heart (2003) 1.32
Proximal myotonic myopathy: a new dominant disorder with myotonia, muscle weakness, and cataracts. Neurology (1994) 1.31
Simultaneous A8344G heteroplasmy and mitochondrial DNA copy number quantification in myoclonus epilepsy and ragged-red fibers (MERRF) syndrome by a multiplex molecular beacon based real-time fluorescence PCR. Nucleic Acids Res (2001) 1.30
High-dose immunoglobulin therapy in sporadic inclusion body myositis: a double-blind, placebo-controlled study. J Neurol (2000) 1.30
Methods for a prompt and reliable laboratory diagnosis of Pompe disease: report from an international consensus meeting. Mol Genet Metab (2007) 1.29
Aequorin luminescence during contraction of amphibian skeletal muscle. J Physiol (1973) 1.28
Radiation dose and leukemia risk in patients treated for cancer of the cervix. J Natl Cancer Inst (1987) 1.28
Vulnerability of the nigrostriatal system as detected by transcranial ultrasound. Neurology (1999) 1.27
Signal sequence recognition in cotranslational translocation by protein components of the endoplasmic reticulum membrane. J Cell Biol (1998) 1.27
Cerebrospinal fluid pterins and folates in Aicardi-Goutières syndrome: a new phenotype. Neurology (2003) 1.27
Scapuloperoneal syndrome type Kaeser and a wide phenotypic spectrum of adult-onset, dominant myopathies are associated with the desmin mutation R350P. Brain (2007) 1.26
Carbohydrate-deficient glycoprotein syndrome type II. J Inherit Metab Dis (1993) 1.26
Rapsyn N88K is a frequent cause of congenital myasthenic syndromes in European patients. Neurology (2003) 1.24